PD-1 + Tim-3 + CD103 + CD8 + Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal Cancer
Anticancer Research · 2026
DOI: 10.21873/anticanres.18125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Daijiro Matoba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Colorectal Neoplasms, Programmed Cell Death 1 Receptor, CD8-Positive T-Lymphocytes.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
- Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
- Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan; tsaito@gesurg.med.osaka-u.ac.jp.
- Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd, Toyonaka, Japan.
Zitieren
APA
Matoba, D., Saito, T., Noda, T., Uemura, M., Ueyama, A., Wada, H., Doki, Y., & Eguchi, H. (2026). PD-1 + Tim-3 + CD103 + CD8 + Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.18125
Vancouver
Matoba D, Saito T, Noda T, Uemura M, Ueyama A, Wada H, et al. PD-1 + Tim-3 + CD103 + CD8 + Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.18125
BibTeX
@article{Matoba2026,
author = {Matoba, Daijiro and Saito, Takuro and Noda, Takehiro and Uemura, Mamoru and Ueyama, Azumi and Wada, Hisashi and Doki, Yuichiro and Eguchi, Hidetoshi},
title = {PD-1 + Tim-3 + CD103 + CD8 + Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal Cancer},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18125}
}
EUVIMED